The pharmacological blockade of SOCE with YM58483/BTP-2, which is a rather selective Orai1 antagonist [80,82,83], reduced collagen secretion, thereby suggesting the therapeutic inhibition of SOCE could provide an alternative strategy to treat myocardial fibrosis in HF [78]. The gene discussed is ORAI1; the disease is hydrops fetalis.